Gossamer Bio (GOSS) Other Non-Current Liabilities (2018)
Gossamer Bio (GOSS) posted quarterly Other Non-Current Liabilities of $718000.0 for Q4 2018.
Gossamer Bio (GOSS) Other Non-Current Liabilities (2018) Analysis & Trends
Gossamer Bio's Other Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $718000.0 for Q4 2018.
- In Q4 2018, Other Non-Current Liabilities changed N/A year-over-year to $718000.0; the TTM figure through Dec 2018 stood at $718000.0 (changed N/A YoY), while the FY2018 annual figure was $718000.0, changed N/A from the prior year.
- Other Non-Current Liabilities for Q4 2018 stood at $718000.0.
- The five-year high for Other Non-Current Liabilities was $718000.0 in Q4 2018, with the low at $718000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 718,000.00 |